Menu

Close

Drug use in special populations

Any drugs that are being used in special populations: Patients with liver and kidney failure, in paediatrics, in geriatrics, and in pregnant or lactating patients. Includes the discovery of factors that could potentially affect drug use in these special populations.

List by Zhang-He Goh

Preprints:

Dosing regimen of gentamicin and the effect of antenatal steroids on clearance in preterm infants

Roberto P. Santos, Yin Chang, Carlos R. Oliveira, Beverly Adams-Huet, John Gard, Pablo J. Sanchez

https://www.biorxiv.org/content/10.1101/566125v1

Gentamicin is a well-known antibiotic that exhibits an uncommon profile in paediatrics, which makes the optimisation of its dosing and administration especially difficult. By targeting this problem in their preprint, Santos et al. help to improve clinical knowledge of gentamicin’s unique dosing regimen in paediatric patients.

Functional potential of bacterial strains in the premature infant gut microbiome is associated with gestational age

Sumayah F Rahman, Matthew R Olm, Michael J Morowitz, Jill F Banfield

https://www.biorxiv.org/content/10.1101/530139v1

Rahman et al. characterise the constitution and diversity of infant gut microbiomes in their preprint, providing insight into “diseases associated with dysbiosis of the microbiome” and, indirectly, shedding light on potential differences in the ways that therapeutics may be administered to paediatric patients.

Categories: pharmacology and toxicology

 

Posted on: 5th June 2019

(No Ratings Yet)




  • Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the pharmacology and toxicology category:

    FENS 2020

    A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020

     



    List by Ana Dorrego-Rivas

    COVID-19 / SARS-CoV-2 preprints

    List of important preprints dealing with the ongoing coronavirus outbreak. See http://covidpreprints.com for additional resources and timeline, and https://connect.biorxiv.org/relate/content/181 for full list of bioRxiv and medRxiv preprints on this topic

     



    List by Gautam Dey, Zhang-He Goh

    1

    Toxicology of toxicants, existing therapeutics, and investigational drugs

    Preprints that describe the toxicology of environmental pollutants and existing and upcoming drugs. Includes both toxicokinetics and toxicodynamics, as well as technological improvements that will help in the characterisation of this field.

     



    List by Zhang-He Goh

    Antimicrobials: Discovery, clinical use, and development of resistance

    Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.

     



    List by Zhang-He Goh

    Anticancer agents: Discovery and clinical use

    Preprints that describe the discovery of anticancer agents and their clinical use. Includes both small molecules and macromolecules like biologics.

     



    List by Zhang-He Goh

    Advances in Drug Delivery

    Advances in formulation technology or targeted delivery methods that describe or develop the distribution of small molecules or large macromolecules to specific parts of the body.

     



    List by Zhang-He Goh
    Close